
**1196627** 

## **WE ARE WE** 

## **Receipts and payments accounts** 

**CC16a** 

**For the period** Period start date Period end date **To from** 1-Apr-24 31-Mar-25 

## **Section A Receipts and payments** 

|**Section A Receipts and payments**|||||
|---|---|---|---|---|
|**A1 Receipts**<br>**5,117**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**5,117**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total receipts_                    5,117**<br>**A3 Payments**<br>Subcontractors<br>**50**<br>Fees and Subscriptions<br>**670**<br>Telephone and Internet<br>**-**<br>Advertisingand Marketing<br>**115**<br>Workshopand events<br>**4,250**<br>Bank Charges<br>**28**<br>Others<br>**-**<br>**-**<br>**-**<br>**_Sub total_                        5,113**<br>**-**<br>**-**<br>**_Sub total_                                -**<br>**_Total payments_                    5,113**<br>**_Net of receipts/(payments)_                           4**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**21**<br>**_Cash funds this year end_                         25**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**|**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**5,117**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**5,117**<br>**-**<br>**-**<br>**-**<br>**5,117**<br>**50**<br>**670**<br>**-**<br>**115**<br>**4,250**<br>**28**<br>**-**<br>**-**<br>**-**<br>**5,113**<br>**-**<br>**-**<br>**-**<br>**5,113**<br>**4**<br>**-**<br>**21**<br>**25**|**Last year**<br>**to the nearest £**|
|||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**5,117**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**5,117**|**-**|
||||||
|||**-**<br>**-**<br>**-**|**-**||
||||**-**|**-**|
||||**-**|**-**|
||||||
|||**-**|**5,117**|**-**|
||||||
|||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**50**|**-**|
||||**670**|**-**|
||||**-**|**-**|
||||**115**|**-**|
||||**4,250**|**-**|
||||**28**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**5,113**|**-**|
||||||
|||**-**<br>**-**<br>**-**|**-**||
||||**-**||
||||**-**|**-**|
||||||
|||**-**|**5,113**|**-**|
||||||
||**-**|**-**<br>**-**<br>**-**<br>**-**|**4**|**-**|
||**-**||**-**|**-**|
||**-**||**21**|**-**|
||**-**||**25**|**-**|





## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>Bank Balance<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>Sinead Rose<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**to nearest £**<br>**25**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**25**<br>**-**<br>OK<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Sinead Rose<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||Sinead Rose|Sinead Rose|2/3/2026|
|||||



